Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
513 rows where has_cryoEM = 0, in_cev_map = 0 and surface_class = "unknown" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
surface_class 1
- unknown · 513 ✖
in_cev_map 1
- - · 513 ✖
has_cryoEM 1
- - · 513 ✖
has_activation_state_pdb_pair 1
- 0 513
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q5IJ48 | Tier 1.5 | 0.593 | 1 | unknown | 1 | 76.44 | 0 | 0 | 0 | 0 | 0 | ventriculomegaly-cystic kidney disease | 0.8112741813611002 | |||||
| Q5JTC6 | Tier 1 | 0.59 | 1 | unknown | 3 | 48.31 | 0 | 0 | 0 | 0 | 0 | osteopathia striata with cranial sclerosis | 0.8010289843367673 | |||||
| P43146 | Tier 1 | 0.587 | 1 | unknown | 9 | 68.19 | 0 | 0 | 0 | 0 | 0 | mirror movements 1 | 0.7894844854575112 | |||||
| Q8WYB5 | Tier 1 | 0.587 | 1 | unknown | 3 | 48.97 | 0 | 0 | 0 | 0 | 0 | genitopatellar syndrome | 0.7887666805196595 | |||||
| Q92794 | Tier 1 | 0.587 | 1 | unknown | 21 | 48.66 | 0 | 0 | 0 | 0 | 0 | autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome | 0.7908994336990406 | |||||
| O60828 | Tier 1 | 0.586 | 1 | unknown | 3 | 70.56 | 0 | 0 | 0 | 0 | 0 | Renpenning syndrome | 0.7876227110842514 | |||||
| O15297 | Tier 1.5 | 0.583 | 1 | unknown | 1 | 67.88 | 0 | 0 | 0 | 0 | 0 | intellectual developmental disorder with gastrointestinal difficulties and high pain threshold | 0.7779617805712467 | |||||
| Q09013 | Tier 1 | 0.574 | 1 | unknown | 2 | 77.62 | 0 | 0 | 0 | 0 | 0 | myotonic dystrophy type 1 | 0.7480475113698601 | |||||
| O60930 | Tier 1.5 | 0.574 | 1 | unknown | 7 | 79.56 | 0 | 0 | 0 | 0 | 0 | progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 | 0.74733857283595 | |||||
| Q6IQ55 | Tier 1 | 0.569 | 1 | unknown | 6 | 48.84 | 0 | 0 | 0 | 0 | 0 | spinocerebellar ataxia type 11 | 0.7308755447203157 | |||||
| O60882 | Tier 1.5 | 0.568 | 1 | unknown | 1 | 83.31 | 0 | 0 | 0 | 0 | 0 | Hypomaturation amelogenesis imperfecta | 0.7281006394540224 | |||||
| O75838 | Tier 1.5 | 0.564 | 1 | unknown | 1 | 88.62 | 0 | 0 | 0 | 0 | 0 | hearing loss, autosomal recessive | 0.7117048435819099 | |||||
| Q15080 | Tier 1 | 0.548 | 1 | unknown | 6 | 84.19 | 0 | 0 | 0 | 0 | 0 | chronic granulomatous disease | 0.6592487859566178 | |||||
| Q9NUW8 | Tier 1 | 0.538 | 1 | unknown | 48 | 80.62 | 0 | 0 | 0 | 0 | 0 | spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1 | 0.6250066855961889 | |||||
| P39086 | Tier 1 | 0.532 | 1 | unknown | 11 | 81.12 | 0 | 0 | 0 | 0 | 0 | epilepsy | 0.6079292940174927 | |||||
| Q6PCD5 | Tier 1 | 0.525 | 1 | unknown | 1 | 70.12 | 0 | 0 | 0 | 0 | 0 | Fanconi anemia, complementation group W | 0.5849156442856244 | |||||
| Q496J9 | Tier 1 | 0.521 | 1 | unknown | 6 | 78.0 | 0 | 0 | 0 | 0 | 0 | botulism | 0.569067134332723 | |||||
| P35568 | Tier 1 | 0.518 | 1 | unknown | 8 | 49.0 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.5600726776459989 | |||||
| P29074 | Tier 1 | 0.511 | 1 | unknown | 8 | 77.19 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5366583695296713 | |||||
| Q9BZC1 | Tier 1 | 0.509 | 1 | unknown | 2 | 61.47 | 0 | 0 | 0 | 0 | 0 | major depressive disorder | 0.5312056211019677 | |||||
| P01579 | Tier 1.5 | 0.498 | 1 | unknown | 8 | 85.31 | 0 | 0 | 0 | 0 | 0 | Primary hemophagocytic lymphohistiocytosis | 0.49197933519665166 | |||||
| Q96QB1 | Tier 1 | 0.494 | 1 | unknown | 7 | 55.88 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.4815591361203349 | |||||
| Q58F21 | Tier 1 | 0.491 | 1 | unknown | 21 | 62.44 | 0 | 0 | 0 | 0 | 0 | male infertility with teratozoospermia due to single gene mutation | 0.46995568999565185 | |||||
| Q9UHK0 | Tier 1 | 0.491 | 1 | unknown | 1 | 55.25 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.4706636090264093 | |||||
| O15075 | Tier 1 | 0.474 | 1 | unknown | 11 | 72.19 | 0 | 0 | 0 | 0 | 0 | mathematical ability | 0.414033055781774 | |||||
| P01563 | Tier 1 | 0.468 | 1 | unknown | 13 | 85.06 | 0 | 0 | 0 | 0 | 0 | renal cell carcinoma | 0.3938654263610389 | |||||
| P42679 | Tier 1 | 0.459 | 1 | unknown | 3 | 83.75 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.36332514256792015 | |||||
| Q1MX18 | Tier 1 | 0.455 | 1 | unknown | 1 | 83.12 | 0 | 0 | 0 | 0 | 0 | diverticular disease | 0.34835781104015423 | |||||
| P49765 | VEGFB | Vascular endothelial growth factor B | Tier 1 | 0.451 | 1 | unknown | 4 | 73.5 | 0 | 0 | 1 | 2 | 27189805 | 0 | diabetic macular edema | 0.3361465485773345 | ||
| Q99619 | Tier 1 | 0.444 | 1 | unknown | 9 | 87.62 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.31278070690952203 | |||||
| Q9H4Z3 | Tier 1 | 0.441 | 1 | unknown | 3 | 80.12 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.30499435066569835 | |||||
| Q8IVL8 | CPO | Carboxypeptidase O | Tier 1 | 0.434 | 1 | unknown | 1 | 87.62 | 0 | 0 | 1 | 2 | 39641920, 39484557 | 0 | Abruptio Placentae | 0.2786958378972539 | ||
| O95393 | Tier 1 | 0.428 | 1 | unknown | 8 | 74.06 | 0 | 0 | 0 | 0 | 0 | colorectal neoplasm | 0.25870589827929125 | |||||
| Q14451 | Tier 1 | 0.416 | 1 | unknown | 14 | 78.0 | 0 | 0 | 0 | 0 | 0 | gallbladder disease | 0.2185260074771684 | |||||
| O43715 | Tier 1 | 0.384 | 1 | unknown | 6 | 87.62 | 0 | 0 | 0 | 0 | 0 | acquired thrombocytopenia | 0.11295587996127908 | |||||
| O15232 | Tier 1.5 | 0.354 | 0 | unknown | 0 | 79.38 | 0 | 0 | 0 | 0 | 0 | multiple epiphyseal dysplasia type 5 | 0.8302929519450023 | |||||
| P00323 | Flavodoxin | Tier 1 | 0.35 | 1 | unknown | 41 | 97.88 | 0 | 0 | 0 | 0 | 0 | ||||||
| P01631 | Ig kappa chain V-II region 26-10 | Tier 1 | 0.35 | 1 | unknown | 19 | 97.62 | 0 | 0 | 0 | 0 | 0 | ||||||
| P00268 | Rubredoxin | Tier 1 | 0.35 | 1 | unknown | 45 | 96.94 | 0 | 0 | 0 | 0 | 0 | ||||||
| Q96JD1 | Tier 1 | 0.35 | 1 | unknown | 3 | 96.5 | 0 | 0 | 0 | 0 | 0 | |||||||
| Q9V2J8 | Tier 1 | 0.35 | 1 | unknown | 41 | 96.56 | 0 | 0 | 0 | 0 | 0 | |||||||
| P04213 | T-cell receptor beta chain V region C5 | Tier 1 | 0.35 | 1 | unknown | 20 | 93.19 | 0 | 0 | 0 | 0 | 0 | ||||||
| Q9UL95 | Tier 1 | 0.35 | 1 | unknown | 1 | 92.88 | 0 | 0 | 0 | 0 | 0 | |||||||
| P58154 | Acetylcholine-binding protein | Tier 1 | 0.35 | 1 | unknown | 67 | 92.06 | 0 | 0 | 0 | 0 | 0 | ||||||
| K7N5N2 | Tier 1 | 0.35 | 1 | unknown | 14 | 91.5 | 0 | 0 | 0 | 0 | 0 | |||||||
| A0N8J3 | Tier 1 | 0.35 | 1 | unknown | 9 | 91.25 | 0 | 0 | 0 | 0 | 0 | |||||||
| Q99T13 | Putative multidrug export ATP-binding/permease protein SAV1866 | Tier 1 | 0.35 | 1 | unknown | 3 | 90.62 | 0 | 0 | 0 | 0 | 0 | ||||||
| P06897 | Histone H2A type 1 | Tier 1 | 0.35 | 1 | unknown | 100 | 90.38 | 0 | 0 | 0 | 0 | 0 | ||||||
| O19626 | B-3501 | Tier 1 | 0.35 | 1 | unknown | 5 | 89.75 | 0 | 0 | 0 | 0 | 0 | ||||||
| Q7NDN8 | glvI | Proton-gated ion channel | Tier 1 | 0.35 | 1 | unknown | 100 | 89.31 | 0 | 0 | 0 | 0 | 0 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;